Late-onset leanness in mice with targeted ablation of melanin concentrating hormone neurons

Tamar Alon1, Jeffrey M Friedman

  • 1Laboratory of Molecular Genetics, The Rockefeller University, New York, New York 10021, USA.

Insights

Loss of melanin concentrating hormone (MCH) neurons causes acquired leanness in mice. Ablating MCH neurons also improved obesity and related conditions in leptin-deficient mice.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Metabolism

Background:

  • Loss of orexin (hypocretin) neurons is linked to narcolepsy.
  • Hypothalamic neurons play a role in regulating body weight.
  • Melanin concentrating hormone (MCH) gene mutations in mice cause leanness.

Purpose of the Study:

  • To investigate if loss of hypothalamic MCH neurons causes acquired changes in body weight.
  • To determine the role of MCH neurons in obesity secondary to leptin deficiency.

Main Methods:

  • Generated mice with selective loss of MCH neurons using a toxin-mediated ablation strategy.
  • Studied body weight, body length, fat mass, lean mass, and leptin levels over 7 weeks.
  • Generated mice deficient in both leptin and MCH neurons to assess MCH neuron role in leptin deficiency-induced obesity.

Main Results:

  • Mice with MCH neuron ablation exhibited reduced body weight, length, fat mass, lean mass, and leptin levels.
  • Leanness in these mice was associated with reduced appetite (hypophagia) and increased energy expenditure.
  • Absence of MCH neurons ameliorated obesity, diabetes, and hepatic steatosis in leptin-deficient mice.

Conclusions:

  • Loss of MCH neurons can lead to acquired leanness.
  • MCH neurons are significant mediators in the response to leptin deficiency.
  • These findings have implications for understanding acquired body weight changes and related clinical conditions.